Podcast

Podcast: This Week in Managed Care - New Direction for CMS Innovation Center, and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top managed care stories included a new direction for the Center for Medicare and Medicaid Innovation; a bipartisan group of governors spoke out against the latest effort to repeal the Affordable Care Act; and the World Health Organization warned that antibiotics currently being developed were not enough to fight antibiotic-resistant infections.

Read more about the stories mentioned in this podcast at the following links:

CMS Innovation Center Seeks New Direction to Encourage Competition, Flexibility

What We're Reading: Walgreens—Rite Aid Deal; Hepatitis Outbreak in LA; Governors on Cassidy-Graham

Antibiotic Development Pipeline Running Thin, WHO Warns

Shingles Vaccination Now Recommended at Age 50

US Psych Congress 2017

Dr Thomas Kosten Highlights Payer Oversight of Opioids

Listen below or through one of these podcast services:

iTunes: http://apple.co/2eYWTss

TuneIn: http://bit.ly/2gv7iwj

Stitcher: http://bit.ly/2gCqtFg

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
Ali Khawar
Ali Khawar
Emma Achola-Kothari, PhD
Dr Emma Achola-Kothani
Dr Emma Achola-Kothari
Casey Koch, PharmD, sitting for a video interview
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo